Fenbendazole, mebendazole, and other antiparasitic compounds have attracted significant research interest for their potential anticancer and antiparasitic properties. This collection brings together clinical case studies, mechanistic research, and practical protocols exploring these compounds.
Available Downloads
- Parasites Are Masters of Disguise
- Fenbendazole as an Anticancer Agent: A Case Series (PMC)
- Fenbendazole: 4 Strategic Anticancer Mechanisms
- Fenbendazole & Ivermectin: 50-in-1 Reference Guide
- Parasitic Origin of Carcinoma: Research Overview
- Parasitic Origin of Cancer: Scientific Perspectives
- Mebendazole: Source Publications & Research Compendium
- Mebendazole in Breast Cancer: HIF Disruption Study (PMC)
- Mebendazole for Ovarian Cancer: Potential & Mechanisms (PMC)
These resources are provided for educational purposes only. Always consult a qualified healthcare provider before beginning any new treatment protocol.
0 comments